Expertise in
1
conditions

Shun-cheng J. Chang

Taipei, TNQ, TW 
Expertise in
1
conditions
Taipei, TNQ, TW 
OverviewLocationsClinical Research

Overview

Shun-cheng Chang practices in Taipei, Taiwan. Chang is highly rated in 1 condition, according to our data. Their top areas of expertise are Necrotizing Fasciitis, Osteomyelitis, Pyoderma Gangrenosum, and Necrosis.

Their clinical research consists of co-authoring 49 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Taipei, TNQ, Taiwan
Other Locations
TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Research Study to Evaluate the Safety and Potential Efficacy of ON101 Cream for the Treatment of Venous Leg Ulcers.
A Research Study to Evaluate the Safety and Potential Efficacy of ON101 Cream for the Treatment of Venous Leg Ulcers.
Enrollment Status: Terminated
Publish Date: March 12, 2025
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Double-blind, Placebo-controlled Clinical Study to Explore the Mechanism of Action (MOA) of ON101 Cream in Patients With Diabetic Foot Ulcers (DFUs).
A Randomized, Double-blind, Placebo-controlled Clinical Study to Explore the Mechanism of Action (MOA) of ON101 Cream in Patients With Diabetic Foot Ulcers (DFUs).
Enrollment Status: Completed
Publish Date: January 05, 2023
Intervention Type: Other, Drug
Study Phase: Not Applicable
Randomized Controlled Study to Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
Randomized Controlled Study to Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
Enrollment Status: Completed
Publish Date: April 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

49 Total Publications

ON101 counteracts oxidative stress and inflammation in radiation-induced dermatitis through Keap1/Nrf2 signaling.
ON101 counteracts oxidative stress and inflammation in radiation-induced dermatitis through Keap1/Nrf2 signaling.
Journal: Life sciences
Published: March 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chang's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile